Thursday, July 3rd, 2025

Shanghai Electric Group Co Ltd: A Strong Technical Buy as Bullish Trends Strengthen

Date of Report

October 28, 2024

Broker Name

CGS International

Company Overview

Shanghai Electric Group Co Ltd is a major global provider of equipment and services in the electric power and industrial sectors. The company specializes in manufacturing and providing a wide range of energy-related products, including power generation equipment and renewable energy solutions.

Stock Performance

  • Last Price: RM2.40
  • Entry Price: RM2.40, RM2.00, RM1.80
  • Stop Loss: RM1.54
  • Targets: RM2.68, RM3.14, RM3.40, RM4.00

Technical Analysis

The stock is categorized as a technical buy, indicating that the bullish trend is both strong and in its early stages. The recent price movements suggest a positive outlook for continued growth.

Investment Recommendation

Investors are encouraged to enter positions at the specified entry price levels, with a stop-loss set at RM1.54. The stock is expected to reach multiple target prices, reflecting its potential for significant appreciation in value as it capitalizes on favorable market conditions.

Mapletree Pan Asia Comm Trust (MPACT SP): Finding a Floor – BUY Rating Maintained 1

Maybank Research Pte Ltd April 30, 2025 Mapletree Pan Asia Commercial Trust (MPACT): Finding a Floor Amid Falling Distributions, Valuation Supports BUY Rating Mapletree Pan Asia Commercial Trust (MPACT SP) faces persistent headwinds, but...

UOB Kay Hian Research increased the target price of Marco Polo Marine(SGX:5LY)

UOB Kay Hian Research has given a positive recommendation for Marco Polo Marine (MPM SP), highlighting the company’s promising outlook due to higher charter rates and its expansion into Korea. Given the increase in...

Innovent Biologics: Pharma Giant in the Making with Strong Growth Prospects

Company Highlights: Innovent Biologics is evolving from a biotech company to a major pharmaceutical player in China, driven by its diverse drug pipeline. Key drugs such as Sintilimab, the company’s leading anti-PD-1 antibody, and...